• Novartis to develop digital therapies with Pear pharmaphorum
    March 06, 2018
    Novartis has joined with one of the rising stars in digital health, Pear Therapeutics, to develop digital therapeutics for patients with schizophrenia and multiple sclerosis.
PharmaSources Customer Service